Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000726892 | SCV001247021 | pathogenic | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001302580 | SCV001491794 | pathogenic | Charcot-Marie-Tooth disease axonal type 2O | 2023-03-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg264 amino acid residue in DYNC1H1. Other variant(s) that disrupt this residue have been observed in individuals with DYNC1H1-related conditions (PMID: 25512093), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DYNC1H1 protein function. ClinVar contains an entry for this variant (Variation ID: 210883). This missense change has been observed in individual(s) with spinal muscular atrophy (PMID: 25609763). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 264 of the DYNC1H1 protein (p.Arg264Gln). |
Gene |
RCV000726892 | SCV002031019 | pathogenic | not provided | 2022-10-19 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25609763, 26100331, 25512093, 32656949) |
Centre de Biologie Pathologie Génétique, |
RCV002273981 | SCV002559113 | likely pathogenic | Neurodevelopmental delay | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV000726892 | SCV003829181 | likely pathogenic | not provided | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV003985080 | SCV004801415 | likely pathogenic | DYNC1H1-related neurological disorders | 2023-10-24 | criteria provided, single submitter | clinical testing | The DYNC1H1 c.791G>A, p.(Arg264Gln) missense variant has been identified in an individual with a phenotype consistent with DYNC1H1-related neurological disorders who demonstrated lower limb malformations, compromised hand function, fine motor difficulties and a brain malformation resembling polymicrogyria by MRI (Scoto et al. 2015). Additionally, a different amino acid substitution at the same codon, p.(Arg264Leu), has been reported in an individual with a phenotype consistent with DYNC1H1-related neurological disorders (Peeters et al. 2015). This variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Multiple lines of computational evidence suggest this variant may impact the gene or gene product. The variant was identified in a de novo state in the proband. Based on the available evidence, the c.791G>A, p.(Arg264Gln) variant is classified as likely pathogenic for DYNC1H1-related neurological disorders. |
Genetic Services Laboratory, |
RCV000193618 | SCV000247224 | uncertain significance | not specified | 2015-06-08 | flagged submission | clinical testing | |
Eurofins Ntd Llc |
RCV000726892 | SCV000703933 | uncertain significance | not provided | 2018-05-01 | flagged submission | clinical testing | |
Inherited Neuropathy Consortium | RCV000789731 | SCV000929108 | uncertain significance | Neuronopathy, distal hereditary motor, autosomal dominant | flagged submission | literature only | ||
Inherited Neuropathy Consortium Ii, |
RCV001302580 | SCV004174347 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2O | 2016-01-06 | flagged submission | literature only |